Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06351085

Enhancing Lung Cancer Screening Through Human-Centered Intervention

The purpose of this study is to further understand the factors involved in increasing lung cancer screening.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California, Davis

Sacramento, California, 95817, United States

About this study

The study aims to identify patient, primary care team and health system factors that facilitate participation in lung cancer screening. Additionally, conduct a two-arm randomized comparative effectiveness intervention study to increase lung cancer screening compared with a usual care control arm and further evaluate the differential impact of the intervention conditions compared to usual care.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Interviews:

  • UC Davis Health Systems (UCDHS) primary care providers and clinic staff who provide services to patients ages 50-80.
  • Patients who are eligible for lung cancer screening.

Screening Intervention:

  • Patients ages 50-80 who have a history of smoking per review of their electronic medical record and who receive care at the following UCDH ambulatory care clinics: Ellison Ambulatory Care Clinic; Elk Grove; Midtown.

Exclusion criteria

Interviews:

  • Non-consenting patients and patients who do not speak English or Spanish
  • Patients aged 49 and younger
  • Non UCDHS primary care providers and clinic staff

Screening Intervention:

  • UCDHS patients who have already received Lung Cancer Screening
  • Patients with existing Cancer diagnosis

Treatment and study plan

Pre-Visit Planner

Behavioral

The study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process.

Pre-Visit Planner + MyChart

Behavioral

The study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process as well as testing if watching educational videos about the Lung Cancer Screening (LCS) process prior to talking to an LVN will help with LCS uptake.

Primary outcomes

  1. Lung Cancer Screening

    Time frame: 156 Weeks

    The primary outcome is the proportion of patients aged 50-80 with a history of smoking who receive Lung Cancer Screening during the study period; this outcome will be measured in both intervention groups and the control group.

Secondary outcomes

  1. Completion of Interviews with Staff and Patients

    Time frame: 156 Weeks

    Key informant interviews with UC Davis staff and patients to determine approach to intervention.

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Registry information

Acronym: ELFE

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Apr 8, 2024
Registry last updated
May 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.